Stefan Keveloh

Avontec is a Phase 2 biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for inflammatory disease. Its clinical development programs include product candidates for multiple potential inflammatory indications. The two most advanced, AVT-01 in asthma and AVT-02 in psoriasis, have successfully advanced into Phase 2a clinical trials that the firm expects to be completed until the first half of 2008. In addition, there are several candidates in the pipeline based on Avontec's core decoy technology. Avontec operates based on a lean business model with a seasoned management team experienced in clinical development.

Part of Deutscher Sparkassen-und Giroverband eV, Sparkasse Göttingen is a financial institution based in Göttingen, Germany. Sparkasse Göttingen provides online banking services and a range of financial products and services for both private and corporate customers. The CEO of the German company is Rainer Hald.